Search
×
FR

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-6 Chapter 6 – Density

$

204

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 560: Fired Heaters for General Refinery Services

$

721

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 64: Diverter Equipment Systems

$

324

BUY NOW

Placeholder headline

This is just a placeholder headline

API MPMS CH 17.10.1: Refrigerated Light Hydrocarbon Fluids – Measurement of Cargoes on Board LNG Carries

$

417

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 13B-1: Testing Water-based Drilling Fluids

$

418

BUY NOW

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-12 Chapter 12 – Thermal Conductivity

$

214

BUY NOW

Placeholder headline

This is just a placeholder headline

API 16FI Frac Iron Guidelines and Requirements

$

129

BUY NOW

ISO 4424:2023

ISO 4424:2023 Genomics informatics – Data elements and their metadata for describing the tumor mutation burden (TMB) information of clinical massive parallel DNA sequencing

CDN $233.00

SKU: e9ef4ca1edf2 Categories: ,

Description

This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.

This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.

This document is not intended

     to define experimental protocols or methods for calculating the value of tumor mutation burden,

     for the other biological species, and

     for the Sanger sequencing methods.

Edition

1

Published Date

2023-12-11

Status

PUBLISHED

Pages

20

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.

This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.

This document is not intended

-     to define experimental protocols or methods for calculating the value of tumor mutation burden,

-     for the other biological species, and

-     for the Sanger sequencing methods.

Previous Editions

Can’t find what you are looking for?

Please contact us at: